TNF[alpha]-inhibition in the treatment of rheumatoid arthritis

著者

• Moreland, Larry W
• Emery, P. (Paul)

書誌事項

TNF[alpha]-inhibition in the treatment of rheumatoid arthritis

edited by Larry W. Moreland, Paul Emery

Martin Dunitz, 2003

注記

Includes bibliographical references and index

内容説明・目次

内容説明

The introduction of tumor-necrosis-factor-alpha (TNFa) blocking agents is one of the milestones in the therapy of rheumatoid arthritis (RA). Edited by Larry Moreland and Paul Emery, experts in rheumatological disease, TNFa-Inhibition in the Treatment of Rheumatoid Arthritis charts the history and development of the concept of TNFa inhibition. The authors document TNFa from its discovery to its now well-documented clinical applications in the treatment of patients with RA. They compare and contrast practical management issues concerning the use of these agents both in the US and UK/Europe. The book is a practical and accessible source containing the most recent information in this field.

目次

Definition of TNFa as a Therapeutic Target for Rheumatoid Arthritis, M. Feldman, F.M. Brennan, R.O. Williams, and R.N. Maini Infliximab Therapy, R.N. Maini and M. Feldman Etanercept, S.Sule and J.M. Bathan Adalimumab, L. van de Putte, J. Salfeld, and S. Kaymakcalan p-55 TNF Receptor Therapy, J.J. Cash TNFa-Inhibition in Practical Management of Rheumatoid Arthritis: The US Model, J.C. Shanahan and L.W. Moreland TNFa-inhibition in Practical Management: The UK/European Model, P. Emery Safety Issues with Anti-TNF Agents: Immunomodulation and Infection, J.C. Shanahan Index

「Nielsen BookData」 より

詳細情報

• NII書誌ID(NCID): BA83789426
• ISBN:
  • 1841841560
• 出版国コード: uk
• タイトル言語コード: eng
• 本文言語コード: eng
• 出版地: London
• ページ数/冊数: viii, 180 p
• 大きさ: 21 cm.
• 分類:
  • DC22 : 616.722706
• 件名:
  • LCSH : Tumor necrosis factor
  • LCSH : Rheumatoid arthritis -- Treatment